• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非免疫功能低下患者膀胱内卡介苗免疫治疗后发生迟发性播散性卡介苗感染并伴有肝脾肿大。

Late-onset disseminated BCG infection with hepatosplenomegaly after intravesical BCG immunotherapy in a non-immunocompromised patient.

作者信息

Hotta Yugi, Yoshioka Naoki, Sakamoto Asami, Inagaki Masayasu, Ito Ryota, Shiraki Kenta, Kiriyama Ayami, Yokoyama Toshihiko, Fujino Masahiko, Doisaki Masao

机构信息

Department of Gastroenterology and Hepatology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, 3-35 Michishita-cho, Nakamura-ku, Nagoya, 453-8511, Japan.

Department of Respiratory Medicine, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, 3-35 Michishita-cho, Nakamura-ku, Nagoya, 453-8511, Japan.

出版信息

Clin J Gastroenterol. 2025 Apr;18(2):337-342. doi: 10.1007/s12328-024-02086-8. Epub 2024 Dec 28.

DOI:10.1007/s12328-024-02086-8
PMID:39731696
Abstract

Intravesical Bacillus Calmette-Guérin (BCG) immunotherapy for bladder cancer rarely leads to disseminated BCG infections, most of which occur early after BCG instillations or in immunocompromised patients. We report late-onset disseminated BCG infection after intravesical BCG immunotherapy in a non-immunocompromised patient. A 78-year-old non-immunocompromised man was admitted with fever and hepatosplenomegaly. He had received intravesical BCG immunotherapy four years earlier. Granulomas were detected in multiple organs and BCG was identified in urine and bone marrow fluid, leading to a diagnosis of disseminated BCG infection. Longitudinal measurements of liver and spleen volumes by computed tomography were useful in determining treatment efficacy.

摘要

膀胱内注射卡介苗(BCG)免疫疗法治疗膀胱癌很少导致播散性卡介苗感染,其中大多数发生在卡介苗灌注后早期或免疫功能低下的患者中。我们报告了一例非免疫功能低下患者在膀胱内注射卡介苗免疫治疗后发生的迟发性播散性卡介苗感染。一名78岁非免疫功能低下男性因发热和肝脾肿大入院。他四年前接受过膀胱内卡介苗免疫治疗。在多个器官中检测到肉芽肿,尿液和骨髓液中发现了卡介苗,从而诊断为播散性卡介苗感染。通过计算机断层扫描对肝脏和脾脏体积进行纵向测量有助于确定治疗效果。

相似文献

1
Late-onset disseminated BCG infection with hepatosplenomegaly after intravesical BCG immunotherapy in a non-immunocompromised patient.非免疫功能低下患者膀胱内卡介苗免疫治疗后发生迟发性播散性卡介苗感染并伴有肝脾肿大。
Clin J Gastroenterol. 2025 Apr;18(2):337-342. doi: 10.1007/s12328-024-02086-8. Epub 2024 Dec 28.
2
Disseminated Bacillus Calmette-Guérin (BCG) infection and acute exacerbation of interstitial pneumonitis: an autopsy case report and literature review.播散性卡介苗(BCG)感染和间质性肺炎急性加重:尸检病例报告及文献复习。
BMC Infect Dis. 2020 Sep 29;20(1):708. doi: 10.1186/s12879-020-05396-7.
3
Super acute-onset disseminated BCG infection: A case report.超急性播散性卡介苗感染:一例报告。
J Infect Chemother. 2023 Sep;29(9):919-921. doi: 10.1016/j.jiac.2023.05.017. Epub 2023 May 23.
4
Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.卡介苗(BCG)膀胱内灌注作为膀胱癌辅助治疗后的感染:单中心系列研究中的发病率、危险因素及结局,并对文献进行综述
Medicine (Baltimore). 2014 Oct;93(17):236-254. doi: 10.1097/MD.0000000000000119.
5
Fever of unknown origin and pancytopenia caused by culture-proven delayed onset disseminated bacillus Calmette-Guerin (BCG) infection after intravesical instillation.膀胱内灌注后经培养证实的迟发性播散性卡介苗(BCG)感染所致不明原因发热和全血细胞减少。
BMJ Case Rep. 2013 Apr 9;2013:bcr2013008949. doi: 10.1136/bcr-2013-008949.
6
Histopathology of Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Immunotherapy for Urothelial Carcinoma.膀胱内卡介苗免疫治疗尿路上皮癌并发播散性牛分枝杆菌感染的组织病理学
Int J Surg Pathol. 2015 May;23(3):189-95. doi: 10.1177/1066896914567332. Epub 2015 Jan 22.
7
Sporotrichoid distributed tuberculous panniculitis as a late complication of intravesical bacillus Calmette-Guérin (BCG) immunotherapy.孢子丝菌病样分布的结核性脂膜炎作为膀胱内卡介苗(BCG)免疫治疗的晚期并发症。
Int J Infect Dis. 2022 Apr;117:247-250. doi: 10.1016/j.ijid.2021.05.003. Epub 2021 May 10.
8
[Disseminated BCG infection in patients with urinary bladder carcinoma].[膀胱癌患者的播散性卡介苗感染]
Med Pregl. 2009 Nov-Dec;62(11-12):592-5. doi: 10.2298/mpns0912592k.
9
A solitary pulmonary nodule caused by Mycobacterium tuberculosis var. BCG after intravesical BCG treatment: a case report.膀胱内卡介苗治疗后由结核分枝杆菌 BCG 变种引起的孤立性肺结节:病例报告。
BMC Pulm Med. 2021 Apr 7;21(1):115. doi: 10.1186/s12890-021-01475-w.
10
A case of disseminated Mycobacterium bovis 2 years post-intravesicular Bacillus Calmette-Guérin therapy for superficial urinary bladder cancer.1例浅表性膀胱癌膀胱内卡介苗治疗2年后播散性牛分枝杆菌感染病例。
Intern Med J. 2017 Jul;47(7):820-823. doi: 10.1111/imj.13475.

本文引用的文献

1
Tissue-based Biomarkers Steering Clinical Decisions in Patients with Urothelial Cancer.基于组织的生物标志物指导尿路上皮癌患者的临床决策
Eur Urol. 2025 Jan;87(1):1-4. doi: 10.1016/j.eururo.2024.08.033. Epub 2024 Sep 11.
2
Latent Tuberculosis Infection.潜伏性结核感染
N Engl J Med. 2021 Dec 9;385(24):2271-2280. doi: 10.1056/NEJMcp2108501.
3
Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision.2019 年日本泌尿外科学会膀胱癌临床实践指南更新:修订概要。
Int J Urol. 2020 Sep;27(9):702-709. doi: 10.1111/iju.14281. Epub 2020 Jun 21.
4
Disseminated Mycobacterium bovis infection post-kidney transplant following remote intravesical BCG therapy for bladder cancer.膀胱癌经尿道膀胱内卡介苗治疗后肾移植术后播散性牛分枝杆菌感染
Transpl Infect Dis. 2018 Oct;20(5):e12931. doi: 10.1111/tid.12931. Epub 2018 Jun 13.
5
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline.非肌肉浸润性膀胱癌的诊断与治疗:AUA/SUO 指南。
J Urol. 2016 Oct;196(4):1021-9. doi: 10.1016/j.juro.2016.06.049. Epub 2016 Jun 16.
6
Efficacy of ruxolitinib on hepatomegaly in patients with myelofibrosis.芦可替尼对骨髓纤维化患者肝肿大的疗效。
Leukemia. 2016 Jun;30(6):1413-5. doi: 10.1038/leu.2015.310. Epub 2015 Nov 3.
7
Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.卡介苗(BCG)膀胱内灌注作为膀胱癌辅助治疗后的感染:单中心系列研究中的发病率、危险因素及结局,并对文献进行综述
Medicine (Baltimore). 2014 Oct;93(17):236-254. doi: 10.1097/MD.0000000000000119.
8
Late Mycobacterium bovis spondylitis after intravesical BCG therapy.膀胱内卡介苗治疗后迟发性牛分枝杆菌脊柱炎
Joint Bone Spine. 2009 May;76(3):296-300. doi: 10.1016/j.jbspin.2008.10.011. Epub 2009 Mar 19.
9
PCR identification of Mycobacterium bovis BCG.牛分枝杆菌卡介苗的聚合酶链反应鉴定
J Clin Microbiol. 1997 Mar;35(3):566-9. doi: 10.1128/jcm.35.3.566-569.1997.
10
Corticosteroid-associated fatal mycobacterial sepsis occurring 3 years after instillation of intravesical bacillus Calmette-Guerin.膀胱内灌注卡介苗3年后发生的与皮质类固醇相关的致命性分枝杆菌败血症。
J Urol. 1993 Nov;150(5 Pt 1):1498-1500. doi: 10.1016/s0022-5347(17)35824-x.